NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=124035&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=124029&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Signet Jewelers Limited ("Signet") (NYSE:SIG) concerning possible violations of federal securities laws. On January 14, 2025, Signet issued a press release announcing the company’s holiday sales results, comprising the 10-week period ending

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Marqeta, Inc. (NASDAQ:MQ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marqeta-inc-lawsuit-submission-form?prid=124043&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=124037&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / NEW YORK, NY / ACCESSWIRE / January 21, 2025 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=124034&wire=1 or

(NYSE:FCN), WASHINGTON, Jan. 21, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the release of its 2025 Global CFO Report, which reveals almost three-quarters (72%) of Chief Financial Officers expect revenue growth of 10% or more over the next 12 months. The survey, which collected the views of 655 senior finance executives

— Record AUM Milestone: Valour has achieved a historic milestone by surpassing US$1 billion in AUM, with a total of US$1.02 billion (C$1.46 billion) as of January 20, 2025. — Strategic Global Expansion: Valour is actively working on expanding its reach into emerging markets through MOUs with AsiaNext and SovFi for listing digital asset ETPs

Callan, a leading institutional investment consulting firm, announced today that Eugene O'Neill, CFA, joined the firm's Fund Sponsor Consulting team as a senior vice president and investment consultant. Mr. O'Neill brings nearly two decades of expertise in institutional consulting and equity portfolio management. He is based in San Francisco and reports to Greg DeForrest, executive

First and only molecular blood test that can both identify bacterial andviral infections and assess need for critical care Precision medicine approachaims to transform emergency triage standard of care TriVerity expected to enable timely and confident decision-making for emergency departments Inflammatix, a pioneering host response diagnostics company, today announced that the U.S. Food and Drug